d-alpha tocopherol has been researched along with Sclerosis, Systemic in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (44.44) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOZKOWA, K | 1 |
| Baroni, SS; Dusi, S; Gabrielli, A; Luchetti, M; Orlandini, G; Paroncini, P; Sambo, P | 1 |
| Broncel, M; Duchnowicz, P; Dworniak, K; Dziankowska-Bartkowiak, B; Gerlicz, Z; Koter-Michalak, M; Waszczykowska, E | 1 |
| Borges, CT; de Souza, RB; Kuruma, KA; Macedo, AR; Macedo, PA | 1 |
| EFE, S | 1 |
| WENIG, H; WESTPHAL, J | 1 |
| SAWA, J; SMAGA, M; SMAJKIEWICZ, L | 1 |
| BANKER, BQ; COOK, CD; ROSEN, FS | 1 |
| FAYOLLE, J; MEUNIER, P | 1 |
| BAGUENA CANDELA, R; BELTRAN BAGUENA, M | 1 |
| Bessard, G; Bessard, J; Boignard, A; Carpentier, PH; Cracowski, JL; Girolet, S; Imbert, B; Seinturier, C; Stanke-Labesque, F | 1 |
| Harada, M; Harada, R; Komai, K; Kumemura, H; Sata, M | 1 |
| Mizutani, H; Sakakura, T; Shimizu, M; Taniguchi, H | 1 |
| Black, CM; Bruckdorfer, KR; Bunce, T; Hillary, JB; Vancheeswaran, R | 1 |
| Black, CM; Bruckdorfer, KR; Bunce, TD | 1 |
| Braganza, JM; Herrick, AL; Hollis, S; Jayson, MI; Rieley, F; Schofield, D | 1 |
| Maeda, M; Matsubara, K; Mori, S | 1 |
| Braganza, JM; Clarke, D; Herrick, AL; Jayson, MI; Rieley, F; Schofield, D; Worthington, H | 1 |
| Hamanaka, H; Mizutani, H; Nouchi, N; Shimizu, M; Yoshida, T | 1 |
| Black, CM; Bruckdorfer, KR; Bunce, TD; Denton, CP; Dorado, MB; Howell, K; Roberts, Z; Wilson, H | 1 |
| Alberto, P; Cerinic, MM; Falcini, F; Fernanda, F; Gabriele, S; Generini, S; Marco, MC; Pignone, A; Sergio, G; Simonini, G | 1 |
| Bernardo, ML; Calvieri, S; De Leva, R; Gurgo Di Castelmenardo, A; Morelli, S; Nuccio, F; Petrilli, AC; Sgreccia, A | 1 |
| Ayres, S; Mihan, R | 1 |
| Walther, H | 1 |
| Turon, R | 1 |
| Kamimura, M | 1 |
| Gerlóczy, F | 1 |
3 review(s) available for d-alpha tocopherol and Sclerosis, Systemic
| Article | Year |
|---|---|
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Endothelium, Vascular; Humans; In Vitro Techniques; Melatonin; Nitric Oxide; Oxidative Stress; Pregnatrienes; Probucol; Raynaud Disease; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Scleroderma, Systemic; Selenium; Stilbenes; Vitamin E | 2000 |
[On the therapy of skin and veneral diseases. Review of the literature 1965-66].
Topics: Adult; Allantoin; Chloramphenicol; Cortisone; Dimethyl Sulfoxide; Erectile Dysfunction; Frostbite; Heparinoids; Herpes Zoster; Humans; Hydrogen Peroxide; Imidazoles; Leg Ulcer; Male; Middle Aged; Nitrofurantoin; Penicillins; Phytotherapy; Plants, Medicinal; Priapism; Prostatitis; Pruritus; Purpura; Pyoderma; Radiodermatitis; Scleroderma, Systemic; Sexually Transmitted Diseases; Skin Diseases; Syphilis; Testosterone; Trichomonas Infections; Urethritis; Varicose Veins; Vitamin E; Warts; Yohimbine | 1968 |
[Vitamin E difficiency in man and the action mechanism of vitamin E].
Topics: Animals; Humans; Scleroderma, Systemic; Vitamin E; Vitamin E Deficiency | 1968 |
4 trial(s) available for d-alpha tocopherol and Sclerosis, Systemic
| Article | Year |
|---|---|
[Increased level of lipid peroxidation products and disturbances in oxidation-reduction balance in erythrocytes from patients suffering from systemic sclerosis, who are chronically treated with vitamin E].
Topics: Catalase; Erythrocytes; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Scleroderma, Systemic; Superoxide Dismutase; Vitamin E | 2013 |
Pentoxyphylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis.
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Fibrosis; Humans; Male; Middle Aged; Pentoxifylline; Scleroderma, Systemic; Skin; Treatment Outcome; Vasodilator Agents; Vitamin E | 2009 |
Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement.
Topics: Adult; Aged; Antioxidants; Blood Flow Velocity; Double-Blind Method; F2-Isoprostanes; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Placebos; Scleroderma, Systemic; Time Factors; Treatment Outcome; Vitamin E | 2005 |
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
Topics: Anticholesteremic Agents; Antioxidants; Ascorbic Acid; Cohort Studies; Humans; Lipoproteins; Lipoproteins, LDL; Nifedipine; Oxidation-Reduction; Probucol; Raynaud Disease; Scleroderma, Systemic; Triglycerides; Vasodilator Agents; Vitamin E | 1999 |
20 other study(ies) available for d-alpha tocopherol and Sclerosis, Systemic
| Article | Year |
|---|---|
[Treatment of scleroderma with alpha-tocopherol].
Topics: alpha-Tocopherol; Basidiomycota; Humans; Scleroderma, Localized; Scleroderma, Systemic; Vitamin E | 1957 |
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Topics: Acetylcysteine; Allopurinol; alpha-Tocopherol; Biphenyl Compounds; Cell Division; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Growth Substances; Humans; Hydrogen Peroxide; Microscopy, Confocal; NADPH Oxidases; Onium Compounds; Oxidative Stress; Phenotype; Phosphoproteins; Protein Transport; Reactive Oxygen Species; Rotenone; Scleroderma, Localized; Scleroderma, Systemic; Skin; Up-Regulation | 2001 |
[Treatment of scleroderma with ACTH and vitamin E].
Topics: Adrenocorticotropic Hormone; Scleroderma, Localized; Scleroderma, Systemic; Vitamin E | 1955 |
[Treatment of scleroderma in newborn with vitamin E].
Topics: Basidiomycota; Child; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Scleroderma, Localized; Scleroderma, Systemic; Vitamin E | 1958 |
[A CASE OF GENERALIZED SCLERODERMA WITH PULMONARY AND OTHER INTERNAL CHANGES].
Topics: Anthracosilicosis; Hemorrhage; Humans; Kidney Diseases; Lung Diseases; Muscular Diseases; Penicillins; Radiography, Thoracic; Salicylates; Scleroderma, Systemic; Vitamin E | 1964 |
DERMATOMYOSITIS AND FOCAL SCLERODERMA.
Topics: Adolescent; Adrenocorticotropic Hormone; Agammaglobulinemia; Child; Cortisone; Dermatomyositis; Diagnosis, Differential; Diseases in Twins; Ergocalciferols; Humans; Neoplasms; Orthopedic Procedures; Orthopedics; Pathology; Physical Therapy Modalities; Radiography; Scleroderma, Localized; Scleroderma, Systemic; Statistics as Topic; Testosterone; Vitamin E | 1963 |
[1ST REMARKS ON THE USE OF THE ALPHA-QUINONE OF TOCOPHEROL IN BALANO-PREPUTIAL SCLEROATROPHY].
Topics: Atrophy; Benzoquinones; Geriatrics; Humans; Male; Penis; Quinones; Scleroderma, Localized; Scleroderma, Systemic; Tocopherols; Vitamin E | 1964 |
[Successful vitamin E therapy of a case of scleroderma with dermatomyositis].
Topics: Dermatomyositis; Humans; Scleroderma, Systemic; Vitamin E | 1950 |
Scleroderma and repeated spontaneous abortions treated with vitamin E--a case report--.
Topics: Abortion, Habitual; Adult; Autoantigens; Female; Humans; Pregnancy; Pregnancy Complications; Ribonucleoproteins; RNA, Small Cytoplasmic; Scleroderma, Systemic; Vitamin E | 2005 |
Nodular scleroderma: focally increased tenascin expression differing from that in the surrounding scleroderma skin.
Topics: Adult; Biopsy; Cell Adhesion Molecules, Neuronal; Diagnosis, Differential; Extracellular Matrix Proteins; Female; Humans; Keloid; Penicillamine; Pronase; Scleroderma, Systemic; Skin; Tenascin; Vitamin E | 1995 |
Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis.
Topics: Aged; Ascorbic Acid; beta Carotene; Carotenoids; Cholesterol; Fatty Acids; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Raynaud Disease; Scleroderma, Systemic; Triglycerides; Vitamin E | 1995 |
Systemic sclerosis, plasma antioxidants and lipids.
Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Cholesterol; Chromatography, High Pressure Liquid; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Scleroderma, Localized; Scleroderma, Systemic; Triglycerides; Vitamin E | 1995 |
Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.
Topics: Aging; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Case-Control Studies; Female; Free Radicals; Humans; Male; Raynaud Disease; Scleroderma, Systemic; Selenium; Sex Factors; Smoking; Trace Elements; Vitamin E | 1994 |
[Systemic scleroderma].
Topics: Adolescent; Adult; Age Factors; Aged; Calcium Channel Blockers; Cause of Death; Child; Female; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Prognosis; Reference Standards; Scleroderma, Systemic; Sex Factors; Vitamin E | 1993 |
Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis.
Topics: Adult; Aged; Amino Acids, Sulfur; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Creatinine; Diet; Energy Intake; Female; Humans; Male; Micronutrients; Middle Aged; Scleroderma, Systemic; Selenium; Smoking; Sulfates; Vitamin E | 1996 |
Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Child, Preschool; Cicatrix, Hypertrophic; Drug Combinations; Female; Humans; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Skin; Tretinoin; Vitamin E | 1999 |
Systemic sclerosis (scleroderma). A case of recovery of cardiomyopathy after vitamin E treatment.
Topics: Antioxidants; Female; Heart Failure; Humans; Middle Aged; Remission Induction; Scleroderma, Systemic; Vitamin E | 2001 |
Is vitamin E involved in the autoimmune mechanism?
Topics: Aged; Autoantibodies; Autoimmune Diseases; Female; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Discoid; Male; Middle Aged; Myositis; Porphyrias; Raynaud Disease; Scleroderma, Localized; Scleroderma, Systemic; Vasculitis; Vitamin E; Vitamin E Deficiency | 1978 |
[Clinical and biological study of the application of alpha-tocopheryl-quinone for 5 years of primary and secondary muscular diseases and for 1 case of scleroderma].
Topics: Adult; Aged; Antihypertensive Agents; Female; Humans; Male; Middle Aged; Muscular Diseases; Quinones; Scleroderma, Systemic; Time Factors; Vitamin E | 1968 |
Comparison of alpha-tocopheryl nicotinate and acetate on skin microcirculation.
Topics: Acetates; Adolescent; Adult; Chilblains; Cyanosis; Drug Synergism; Female; Humans; Male; Microcirculation; Middle Aged; Nicotinic Acids; Raynaud Disease; Scleroderma, Systemic; Skin; Skin Diseases; Structure-Activity Relationship; Temperature; Time Factors; Vitamin E | 1974 |